CRISPR Therapeutics
CRSP
CRSP
470 hedge funds and large institutions have $4.02B invested in CRISPR Therapeutics in 2025 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 149 increasing their positions, 123 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.79% more ownership
Funds ownership: 79.42% → 80.21% (+0.79%)
14% less capital invested
Capital invested by funds: $4.68B → $4.02B (-$659M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
470
Holding in Top 10
6
Calls
$233M
Puts
$172M
Top Buyers
| 1 | +$58M | |
| 2 | +$44M | |
| 3 | +$34.8M | |
| 4 |
BlackRock
New York
|
+$27.4M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$14.6M |
Top Sellers
| 1 | -$43.8M | |
| 2 | -$34.4M | |
| 3 | -$24.6M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$18M |
| 5 |
State Street
Boston,
Massachusetts
|
-$15.2M |
